MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 1045-1049

  Riesenberg, Anne ^a,b   Feßler, Andrea T ^a   Erol, Erdal ^c   Prenger Berninghoff, Ellen ^d   Stamm, Ivonne ^e   Böse, Reinhard ^f   Heusinger, Anton ^g   Klarmann, Dieter ^b   Werckenthin, Christiane ^b   Schwarz, Stefan ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

^c UNIVERSITY OF KENTUCKY   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e Vet Med Labor GmbH   (Germany)

^f Labor Dr Böse GmbH   (Germany)

^g LABOKLIN GMBH AND CO KG   (Germany)

Author keywords

Broth microdilution; Horses; Rifampicin; RpoB

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; APRAMYCIN; AZITHROMYCIN; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFQUINOME; CEFTIOFUR; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ENROFLOXACIN; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; PENICILLIN G; PIRLIMYCIN; RIFAMPICIN; SPIRAMYCIN; TETRACYCLINE; TILMICOSIN; TULATHROMYCIN; TYLOSIN TARTRATE; UNINDEXED DRUG; VANCOMYCIN;

AMINO ACID SUBSTITUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HORSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; RHODOCOCCUS EQUI;

BROTH MICRODILUTION; HORSES; RIFAMPICIN; RPOB;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTI-INFECTIVE AGENTS; DNA-DIRECTED RNA POLYMERASES; EUROPE; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; RHODOCOCCUS EQUI; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84896459678     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt460     Document Type: Article

References (23)

1. von Bargen K, Haas A. Molecular and infection biology of the horse pathogen Rhodococcus equi. FEMS Microbiol Rev 2009; 33: 870-91.
2. Prescott JF, Hoffman AM. Rhodococcus equi. Vet Clin North Am Equine Pract 1993; 9: 375-84.
3. Kedlaya I, Ing MB, Wong SS. Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin Infect Dis 2001; 32: E39-46.
4. Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes-Second Edition: Approved Standard M24-A2. CLSI,Wayne, PA, USA, 2011.
5. Giguère S, Jacks S, Roberts GD et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 2004; 18: 568-73.
6. Sweeney CR, Sweeney RW, Divers TJ. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Microbiol 1987; 14: 329-36.
7. Animal Medicinal Drug Use Clarification Act (AMDUCA). http://www.avma. org/KB/Resources/Reference/Pages/AMDUCA.aspx (3 October 2013, date last accessed).
8. Fines M, Pronost S, Maillard K et al. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J Clin Microbiol 2001; 39: 2784-7.
9. Kadlec K, van Duijkeren E, Wagenaar JA et al. Molecular basis of rifampicin resistance in methicillin-resistant Staphylococcus pseudintermedius isolates from dogs. J Antimicrob Chemother 2011; 66: 1236-42.
10. Asoh N, Watanabe H, Fines-Guyon M et al. Emergence of rifampinresistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand. J ClinMicrobiol 2003; 41: 2337-40.
11. Boyen F, Pasmans F, Haesebrouck F. Acquired antimicrobial resistance in equine Rhodococcus equi isolates. Vet Rec 2011; 168: 101a.
12. Burton AJ, Giguère S, Sturgill TL et al. Macrolide-and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA. Emerg Infect Dis 2013; 19: 282-5.
13. Niwa H, Hobo S, Anzai T et al. Antimicrobial susceptibility of 616 Rhodococcus equi strains isolated from tracheobronchial aspirates of foals suffering fromrespiratory disease in Japan. J Equine Sci 2005; 16: 99-104.
14. Nordmann P, Ronco E. In-vitro antimicrobial susceptibilityofRhodococcus equi. J Antimicrob Chemother 1992; 29: 383-93.
15. Rothhaar E. On the development of antibiotic sensitivity by R. equi. Doctoral Thesis (in German language). University of Veterinary Medicine Hannover, Foundation, Hannover, Germany, 2006. http://d-nb.info/980904633/34 (5 April 2013, date last accessed).
16. Carlson KL, Kuskie KR, Chaffin KM et al. Antimicrobial activity of tulathromycin and 14 other antimicrobials against virulent Rhodococcus equi in vitro. Vet Ther 2010; 11: E1-9.
17. Hollberg A. Examination of antibiotic sensitivity by Rhodococcus equi in German foals. Doctoral Thesis (in German language). University of Veterinary Medicine Hannover, Foundation, Hannover, Germany, 2011. http://elib. tiho-hannover.de/dissertations/hollberga_ws11.pdf (21 July 2013, date last accessed).
18. Jacks SS, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. Antimicrob Agents Chemother 2003; 47: 1742-5.
19. Riesenberg A, Feßler AT, Frömke C et al. Harmonization of antimicrobial susceptibility testing by broth microdilution for Rhodococcus equi of animal origin. J Antimicrob Chemother 2013; 68: 2173-5.
20. Ladrón N, Fernández M, Agüero J et al. Rapid identification of Rhodococcus equi by a PCR assay targeting the choE gene. J Clin Microbiol 2003; 41: 3241-5.
21. Makadia JS, Jain A, Patra SK et al. Emerging trend of mutation profile of rpoB gene in MDR tuberculosis, North India. Indian J Clin Biochem 2012; 27: 370-4.
22. Zaczek A, Brzostek A, Augustynowicz-Kopec E et al. Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin. BMC Microbiol 2009; 9: 10.
23. Cruchaga S, Pérez-Vázquez M, Román F et al. Molecular basis of rifampicin resistance in Haemophilus influenzae. J Antimicrob Chemother 2003; 52: 1011-4.